Novo Nordisk warns of 2026 sales declineCOPENHAGEN, Feb 3 (Reuters) - Wegovy maker Novo Nordisk NOVOb.CO expects a decline in sales this year, it said on Tuesday as it reported fourth-quarter operating profit slightly above forecasts.
(Reporting by Jacob Gronholt-Pedersen, Maggie Fick and Stine JacobsenEditing by David Goodman)
((stine.jacobsen@thomsonreuters.com; +45 2156 9010))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments